Company Profile
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Latest News
Thai vehicle sales rise 17% in June
EQT raises Perpetual bid to about A$2.6bn
If I Only Had $500 to Invest, This Is the ETF I'd Buy Right Now
Back-to-School 2026: In-Store Shopping Dominates as Canadian Parents Navigate $4.5 Billion Season
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Website | https://www.sartorius.com |
| Audit Risk | 2 |
| Board Risk | 6 |
| Overall Risk | 8 |
| Market Cap | 15.20B |
| Trailing P/E | 77.77 |
| Forward P/E | 34.86 |
| Dividend Rate | 0.74 |
| Dividend Yield | 0.33% |
| Trailing Annual Div. Rate | 0.74 |
| Trailing Annual Div. Yield | 0.33% |
| Trailing EPS | 2.83 |
| Forward EPS | 6.31 |
| Book Value | 39.2 |
| Price-to-Book | 5.61 |
| Enterprise-to-Revenue | 5.64 |
| Enterprise-to-EBITDA | 21.52 |
| Ex-Dividend Date | 03/27/2026 |
| Earnings Date | |
| Earnings Call Date | |
| Earnings Average | 1.23 |
| Earnings Low | 1.13 |
| Earnings High | 1.29 |
| Revenue Average | 897.82M |
| Revenue Low | 890.00M |
| Revenue High | 909.08M |